Remove Clinical Development Remove Clinical Research Remove Development Remove Drug Trials
article thumbnail

This week in drug discovery (6-10 February)

Drug Discovery World

Clinical drug trials have made the headlines this week, as it was revealed that breast cancer still tops the bill for number of clinical studies and the shortcomings in current methods to ensure representation of patient populations in trials were exposed.

Drugs 52
article thumbnail

Steps to building a more patient-centric industry

pharmaphorum

A recent survey of clinical trial professionals found that more than two-thirds of respondents (61%) believe giving patients choice will have a positive impact on clinical research, and well over half (58%) said that their organisations plan to give patients the option to choose how they participate in clinical trials moving forward.

article thumbnail

Unlocking the potential in rare disease research with decentralised trials

pharmaphorum

A survey of members of the Raremark community found that 86% of respondents were interested in taking part in a clinical trial now or in the future. Research and development will always be important to rare disease patients. A few others said they would struggle to comprehend all the trial literature on their own.

Trials 118